| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07ead23f59e0c2e72c67c1c417d96ccf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_276c423bb47c232ccd8ed10f3e2ce65e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01dd81171a860e7c355d1d41d39439c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08a578ae3f19764ee6ae0b22708d98a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d9a31243981e8241cc00b1f1094bc23 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-059 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10 |
| filingDate |
2011-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5b1e0389e28f43ec97e5cff6b3d8ddb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b8f4251b279a1e1706e9d3a5d546d0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0c7d475e9396d8455bc72fbba567f18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07cd0451e3855502fd3d90a1a76feda5 |
| publicationDate |
2012-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012064963-A1 |
| titleOfInvention |
Anchorage devices comprising an active pharmaceutical ingredient |
| abstract |
An anchorage device 100 comprising a mesh substrate 124 coupled to an implantable medical device 120 is disclosed, where the mesh substrate has a coating 120 comprising a polymer, and the mesh further comprises at least one active pharmaceutical ingredient. The active pharmaceutical agent is designed to elute from the device over time. The mesh substrate can be configured to reduce the mass of the anchorage device such that tissue in-growth and/or scar tissue formation at the treatment site is reduced. In some embodiments, the mesh substrate can be formed with a mesh having a low areal density. In some embodiments, the mesh substrate can include one or more apertures or pores to reduce the mass of the substrate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4129350-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3586886-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022216259-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11224570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2023079760-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11202754-B2 |
| priorityDate |
2010-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |